Daily Bulletin

Men's Weekly

.

Aravax Pty Ltd announces opening of IND for Phase 2 clinical trials of PVX108, a next-generation immunotherapy for the treatment of peanut allergy

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
  • Phase 2 study of PVX108 to commence in United States and Australia
  • Dr Robert A. Wood, professor of pediatrics at the Johns Hopkins University School of Medicine, joins Scientific Advisory Board

MELBOURNE, Australia, March 4, 2022 /PRNewswire/ -- Aravax, a clinical stage biotechnology company focused on developing the first therapy for peanut...

Read more: Aravax Pty Ltd announces opening of IND for Phase 2 clinical trials of PVX108, a next-generation...

Business News

Automotive Expert, Raffy Sgroi, Warns: Australia is Building Snowflakes in the Desert with EV Policy

With the National Electric Vehicle Strategy due for a comprehensive review during 2026, automotive expert and senior government advisor, Raffy Sgroi, warns that Australia is rushing electric vehic...

Daily Bulletin - avatar Daily Bulletin

China Gold Coin Group Launched 2026 Chinese Dragon Silver Bullion Coin at World Money Fair in Berlin

China Gold Coin Group Co., Ltd. unveiled its 2026 Chinese Dragon Silver Bullion Coin at the World Money Fair held in Berlin, Germany, from January 29 to 31. Led by Mr Jinpu Jiao, Chairman of the Boa...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Industrial Air Compressor for Your Business

Running a business is all about making the right decisions. When it comes to choosing an industrial air compressor, that decision becomes even more critical. Air compressors are long-term investment...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business